v3.24.3
Interim Condensed Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating activities    
Net loss for the period $ (33,127) $ (25,184)
Items not affecting cash:    
Stock based compensation 965 779
Inventory net realizable value adjustments 2,061 8,158
Amortization of mineral properties 205 828
Depreciation of capital assets 1,979 1,546
Accretion expense 518 371
Amortization of deferred loan costs 33 33
Provision for reclamation (6) 0
Warrant liability revaluation loss (gain) (4,442) 4,155
Gain on sale of capital assets (2) 0
Foreign exchange gain (22) (329)
Changes in non-cash working capital:    
Trade receivables (27) 5,600
Lease receivable (520) 0
Inventory (3,736) (2,956)
Prepaid expenses 623 (565)
Accounts payable and accrued liabilities 3,011 2,105
Cash provided by used in operating activities (32,487) (16,659)
Investing activities    
Purchase of capital assets (5,701) (1,923)
Cash provided by used in investing activities (5,701) (1,923)
Financing activities    
Issuance of common shares for cash 97,568 46,637
Share issue costs 4,683 (3,002)
Proceeds from exercise of warrants and stock options 12,228 969
RSUs redeemed for cash (56) (81)
Repayment of debt (5,727) (4,027)
Cash provided by used in financing activities 99,330 40,496
Effects of foreign exchange rate changes on cash (34) 7
Increase in cash, cash equivalents, and restricted cash and cash equivalents 61,108 21,921
Beginning cash, cash equivalents, and restricted cash and cash equivalents 68,249 41,140
Ending cash, cash equivalents, and restricted cash and cash equivalents $ 129,357 $ 63,061

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL